New

Ready-made ETF portfolios built for real investor needs. Explore now →

Advertisement
Advertisement

WDNAvsHRTSETF Comparison

ETF 1
WDNA

WisdomTree BioRevolution Fund

This fund is part of
BioTech & Genomics
-0.12%
VS
ETF 2
HRTS

Tema GLP-1, Obesity & Cardiometabolic ETF

This fund is part of
Tomorrow's Treatments
-0.74%

WisdomTree BioRevolution Fund (WDNA) belongs to the BioTech & Genomics segment. Tema GLP-1, Obesity & Cardiometabolic ETF (HRTS) is part of the Tomorrow's Treatments segment. WDNA's top 3 sector exposures are Health Care, Materials and Consumer Staples. In contrast, HRTS's top sector exposures are Health Care,  WDNA is less expensive with a Total Expense Ratio (TER) of 0.45%, versus 0.99% for HRTS. WDNA is up 4.41% year-to-date (YTD) with -$357K in YTD flows. HRTS performs worse with -6.25% YTD performance, and -$2M in YTD flows. Run a side-by-side ETF comparison of WDNA and HRTS below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios.  Discover our library of Model portfolios

WDNA vs HRTS performance and flow charts

Performance

024681012%Mar 27Apr 6Apr 13Apr 20Apr 27

Cumulative Flows

-1.4 M-1.2 M-1 M-0.8 M-0.6 M-0.4 M-0.2 M0 MMar 27Apr 6Apr 13Apr 20Apr 27

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Historic performance and flows
Data as of 04/27/2026
1M3MYTD1Y3Y5Y
Perf.
WDNA
HRTS
+5.78%+1.43%
-4.95%-8.36%
+4.41%-6.25%
+41.36%+16.87%
+11.54%n/a
n/an/a
Flows
WDNA
HRTS
--$1M
-$357K-$4M
-$357K-$2M
-$357K-$12M
-$524K-
--
Volatility and drawdown
3M1Y3Y5Y
Volatility
WDNA
HRTS
+24.01%+16.53%
+26.79%+16.33%
+24.80%n/a
n/an/a
Max drawdown
WDNA
HRTS
-10.14%-9.68%
-11.90%-10.68%
-37.80%n/a
n/an/a
Max drawdown duration
WDNA
HRTS
79d57d
95d110d
901dn/a
n/an/a
Trading data

Create an account to view trading data

Join for free
WDNA
HRTS
Last sale
4/28/2026 at 1:30 PM
$17.65
$33.15
Previous close
04/27/2026
$17.70
$33.10
Consolidated volume
04/27/2026
Average volume
30 days
Average discount or premium
30 days
Average Bid/Ask spread
30 days
Replication quality
Data as of April 29, 2026
1-year trailing difference

Create an account to view replication metrics

Join for free

HRTS
is actively managed and doesn’t replicate an index

Create an account to view replication quality

Join for free
WDNA
HRTS
Tracking error
Tracking difference
1 year cumulative return difference
Best
Worst
Daily return difference
Average
Worst
Advertisement
Main metrics
Last update 4/28/2026 at 1:30 PM
Live
Closed
WDNA
HRTS
Last price
$17.65
$33.15
1D performance
-0.28%
+0.15%
AuM$2.30 M$49.35 M
E/R0.45%0.99%
Characteristics
WDNA
HRTS
Management strategyPassiveActive
ProviderWisdomTreeTema
BenchmarkWisdomTree BioRevolution Index-
N° of holdings7538
Asset classEquities-
Trailing 12m distribution yield
Join
Join
Inception dateJune 3, 2021November 21, 2023
ESGNoNo
Advertisement
Exposure

Countries

WDNA
USA
80.59%
Other
19.41%
HRTS
USA
82.47%
Other
17.53%

Sectors

WDNA
Health Care
82.52%
Other
17.48%
HRTS
Health Care
87.86%
Other
12.14%

Diversification

WDNA

Total weight of top 15 holdings out of 15

38.65%
HRTS

Total weight of top 15 holdings out of 15

61.52%

Top 15 holdings

Data as of March 31, 2026
WDNA
MODERNA INC
4.49%
JOHNSON&JOHNSON
3.26%
UTD THERAPEUT
2.90%
PFIZER
2.82%
LILLY
2.65%
STOKE THERAPEUTICS INC
2.57%
NATERA
2.46%
AMGEN-T
2.43%
ASTRAZENECA
2.34%
AMICUS THERAPEUTICS
2.28%
TWIST BIOSCIENCE CORP
2.20%
BIONTECH SE ADR
2.09%
US86366E1064
2.09%
IONIS PHARMACEUTICALS INC
2.07%
GILEAD SCIENCES
2.00%
HRTS
LILLY
9.70%
JOHNSON&JOHNSON
4.97%
US7711951043
4.94%
ASTRAZENECA
4.91%
MERCK & CO INC
4.46%
THERMO FISHER SCIENTIFIC
4.06%
UNITEDHEALTH GRP
3.79%
GILEAD SCIENCES
3.66%
NOVARTIS
3.52%
VERTEX PHARMACEUTICALS
3.30%
ABBOTT LABS
3.26%
ABBVIE
3.00%
BRIDGEBIO PHARMA
2.85%
DANAHER
2.81%
BRISTOL-MYERS SQUIBB
2.29%
Frequently asked questions about WDNA and HRTS

How have the WDNA and HRTS ETFs performed in 2026?

As of April 27, 2026, WDNA is up 4.41% year-to-date (YTD), while HRTS has lost -6.25%. That puts WDNA better performer ahead so far this year.

Which ETF is attracting more investor money: WDNA or HRTS?

Year-to-date, the WDNA ETF saw -$357K in flows, compared to -$2M for HRTS.

Which ETF is more volatile: WDNA or HRTS?

Over the past year, WDNA had a volatility of 26.79%, while HRTS experienced 16.33%.

Which ETF is bigger: WDNA or HRTS?

As of April 27, 2026, WDNA holds $2.30 M in assets under management (AUM), while HRTS manages $49.35 M.

What sectors do the WDNA and HRTS ETFs invest in?

WDNA leans toward sectors like Health Care. Meanwhile, HRTS focuses on Health Care.

What are the top holdings of the WDNA ETF and HRTS ETF?

WDNA top holdings include MODERNA INC, JOHNSON&JOHNSON and UTD THERAPEUT. HRTS holds in its top three: LILLY, JOHNSON&JOHNSON and US7711951043.

Which ETF is more diversified: WDNA or HRTS?

WDNA holds 84 securities with 38.65% of its assets in the top 15. HRTS has 44 securities and a top 15 weight of 61.52%.

Advertisement
Advertisement
Advertisement
The Active Trader Report

Active Trader Report: Use of Leveraged & Inverse ETFs Way Up

Direxion partnered with Compound Insights and Vanda to explore what’s driving the evolution of active trading — and how active traders are using leveraged and inverse funds across equities, single stocks, commodities, and volatility.

Active Trader Report: Use of Leveraged & Inverse ETFs Way Up